A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors

Several mechanisms have been described to elucidate the emergence of resistance to MAPK inhibitors in melanoma and there is a crucial need for biomarkers to identify patients who are likely to achieve a better and long-lasting response to BRAF inhibitors therapy. In this study, we developed a target...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Louveau, Baptiste, Delyon, Julie, De Moura, Coralie Reger, Battistella, Maxime, Jouenne, Fanelie, Golmard, Lisa, Sadoux, Aurelie, Podgorniak, Marie-Pierre, Chami, Ichrak, Marco, Oren, Caramel, Julie, Dalle, Stephane, Feugeas, Jean-Paul, Dumaz, Nicolas, Lebbe, Celeste, Mourah, Samia
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2019
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6422198/
https://ncbi.nlm.nih.gov/pubmed/30899440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26707
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg